ID   BMR1B_HUMAN             Reviewed;         502 AA.
AC   O00238; B2R953; B4DSV1; P78366;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1997, sequence version 1.
DT   10-MAY-2017, entry version 182.
DE   RecName: Full=Bone morphogenetic protein receptor type-1B;
DE            Short=BMP type-1B receptor;
DE            Short=BMPR-1B;
DE            EC=2.7.11.30;
DE   AltName: CD_antigen=CDw293;
DE   Flags: Precursor;
GN   Name=BMPR1B;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Prostate;
RX   PubMed=9178898; DOI=10.1038/sj.onc.1200964;
RA   Ide H., Katoh M., Sasaki H., Yoshida T., Aoki K., Nawa Y., Osada Y.,
RA   Sugimura T., Terada M.;
RT   "Cloning of human bone morphogenetic protein type IB receptor (BMPR-
RT   IB) and its expression in prostate cancer in comparison with other
RT   BMPRs.";
RL   Oncogene 14:1377-1382(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Ovary;
RX   PubMed=10051328; DOI=10.1007/s003359900990;
RA   Astroem A.-K., Jin D.F., Imamura T., Roijer E., Rosenzweig B.,
RA   Miyazono K., ten Dijke P., Stenman G.;
RT   "Chromosomal localization of three human genes encoding bone
RT   morphogenetic protein receptors.";
RL   Mamm. Genome 10:299-302(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain, and Uterus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=PNS;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   INTERACTION WITH GDF5.
RX   PubMed=24098149; DOI=10.1371/journal.pgen.1003846;
RA   Degenkolbe E., Konig J., Zimmer J., Walther M., Reissner C.,
RA   Nickel J., Ploger F., Raspopovic J., Sharpe J., Dathe K., Hecht J.T.,
RA   Mundlos S., Doelken S.C., Seemann P.;
RT   "A GDF5 point mutation strikes twice--causing BDA1 and SYNS2.";
RL   PLoS Genet. 9:E1003846-E1003846(2013).
RN   [8]
RP   VARIANTS BDA2 LYS-200 AND TRP-486.
RX   PubMed=14523231; DOI=10.1073/pnas.2133476100;
RA   Lehmann K., Seemann P., Stricker S., Sammar M., Meyer B., Suering K.,
RA   Majewski F., Tinschert S., Grzeschik K.-H., Mueller D., Knaus P.,
RA   Nuernberg P., Mundlos S.;
RT   "Mutations in bone morphogenetic protein receptor 1B cause
RT   brachydactyly type A2.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:12277-12282(2003).
RN   [9]
RP   INVOLVEMENT IN AMDD.
RX   PubMed=15805157; DOI=10.1136/jmg.2004.023564;
RA   Demirhan O., Tuerkmen S., Schwabe G.C., Soyupak S., Akguel E.,
RA   Tastemir D., Karahan D., Mundlos S., Lehmann K.;
RT   "A homozygous BMPR1B mutation causes a new subtype of acromesomelic
RT   chondrodysplasia with genital anomalies.";
RL   J. Med. Genet. 42:314-317(2005).
RN   [10]
RP   VARIANT BRACHYDACTYLY TYPE C/BDA2 GLN-486.
RX   PubMed=16957682; DOI=10.1038/sj.ejhg.5201708;
RA   Lehmann K., Seemann P., Boergermann J., Morin G., Reif S., Knaus P.,
RA   Mundlos S.;
RT   "A novel R486Q mutation in BMPR1B resulting in either a brachydactyly
RT   type C/symphalangism-like phenotype or brachydactyly type A2.";
RL   Eur. J. Hum. Genet. 14:1248-1254(2006).
RN   [11]
RP   VARIANTS [LARGE SCALE ANALYSIS] HIS-31; TRP-149; HIS-224; ASN-297 AND
RP   GLN-371.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
RN   [12]
RP   VARIANT AMDD ARG-53, AND CHARACTERIZATION OF VARIANT AMDD ARG-53.
RX   PubMed=24129431; DOI=10.1038/ejhg.2013.222;
RA   Graul-Neumann L.M., Deichsel A., Wille U., Kakar N., Koll R.,
RA   Bassir C., Ahmad J., Cormier-Daire V., Mundlos S., Kubisch C.,
RA   Borck G., Klopocki E., Mueller T.D., Doelken S.C., Seemann P.;
RT   "Homozygous missense and nonsense mutations in BMPR1B cause
RT   acromesomelic chondrodysplasia-type Grebe.";
RL   Eur. J. Hum. Genet. 22:726-733(2014).
RN   [13]
RP   INVOLVEMENT IN BDA1D, VARIANT BDA1D ASN-325, AND CHARACTERIZATION OF
RP   VARIANT BDA1D ASN-325.
RX   PubMed=25758993; DOI=10.1038/ejhg.2015.38;
RA   Racacho L., Byrnes A.M., MacDonald H., Dranse H.J., Nikkel S.M.,
RA   Allanson J., Rosser E., Underhill T.M., Bulman D.E.;
RT   "Two novel disease-causing variants in BMPR1B are associated with
RT   brachydactyly type A1.";
RL   Eur. J. Hum. Genet. 23:1640-1645(2015).
RN   [14]
RP   VARIANT AMDD CYS-31, AND CHARACTERIZATION OF VARIANT AMDD CYS-31.
RX   PubMed=26105076; DOI=10.1186/s13023-015-0299-5;
RA   Stange K., Desir J., Kakar N., Mueller T.D., Budde B.S., Gordon C.T.,
RA   Horn D., Seemann P., Borck G.;
RT   "A hypomorphic BMPR1B mutation causes du Pan acromesomelic
RT   dysplasia.";
RL   Orphanet J. Rare Dis. 10:84-84(2015).
CC   -!- FUNCTION: On ligand binding, forms a receptor complex consisting
CC       of two type II and two type I transmembrane serine/threonine
CC       kinases. Type II receptors phosphorylate and activate type I
CC       receptors which autophosphorylate, then bind and activate SMAD
CC       transcriptional regulators. Receptor for BMP7/OP-1 and GDF5.
CC       Positively regulates chondrocyte differentiation through GDF5
CC       interaction. {ECO:0000250|UniProtKB:P36898}.
CC   -!- CATALYTIC ACTIVITY: ATP + [receptor-protein] = ADP + [receptor-
CC       protein] phosphate.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000250};
CC   -!- SUBUNIT: Interacts with high affinity with GDF5; positively
CC       regulates chondrocyte differentiation.
CC       {ECO:0000269|PubMed:24098149}.
CC   -!- INTERACTION:
CC       P12643:BMP2; NbExp=3; IntAct=EBI-7527193, EBI-1029262;
CC       P43026:GDF5; NbExp=7; IntAct=EBI-7527193, EBI-8571476;
CC   -!- SUBCELLULAR LOCATION: Cell membrane
CC       {ECO:0000250|UniProtKB:P36898}. Membrane; Single-pass type I
CC       membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O00238-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O00238-2; Sequence=VSP_045100;
CC   -!- DISEASE: Acromesomelic dysplasia, Demirhan type (AMDD)
CC       [MIM:609441]: A form of chondrodysplasia. Acromesomelic
CC       chondrodysplasias are rare hereditary skeletal disorders
CC       characterized by short stature, very short limbs and hand/foot
CC       malformations. The severity of limb abnormalities increases from
CC       proximal to distal with profoundly affected hands and feet showing
CC       brachydactyly and/or rudimentary fingers (knob-like fingers).
CC       {ECO:0000269|PubMed:15805157, ECO:0000269|PubMed:24129431,
CC       ECO:0000269|PubMed:26105076}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Brachydactyly A2 (BDA2) [MIM:112600]: A form of
CC       brachydactyly. Brachydactyly defines a group of inherited
CC       malformations characterized by shortening of the digits due to
CC       abnormal development of the phalanges and/or the metacarpals. In
CC       brachydactyly type A2 shortening of the middle phalanges is
CC       confined to the index finger and the second toe, all other digits
CC       being more or less normal. Because of a rhomboid or triangular
CC       shape of the affected middle phalanx, the end of the second finger
CC       usually deviates radially. {ECO:0000269|PubMed:14523231,
CC       ECO:0000269|PubMed:16957682}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Brachydactyly A1, D (BDA1D) [MIM:616849]: A form of
CC       brachydactyly type A1. Brachydactyly defines a group of inherited
CC       malformations characterized by shortening of the digits due to
CC       abnormal development of the phalanges and/or the metacarpals.
CC       Brachydactyly type A1 is characterized by middle phalanges of all
CC       the digits rudimentary or fused with the terminal phalanges. The
CC       proximal phalanges of the thumbs and big toes are short. BDA1D
CC       inheritance is autosomal dominant. {ECO:0000269|PubMed:25758993}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. TKL Ser/Thr
CC       protein kinase family. TGFB receptor subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D89675; BAA19765.1; -; mRNA.
DR   EMBL; U89326; AAC28131.1; -; mRNA.
DR   EMBL; AK299930; BAG61763.1; -; mRNA.
DR   EMBL; AK313642; BAG36400.1; -; mRNA.
DR   EMBL; AC004061; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC092609; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC093634; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC105395; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471057; EAX06060.1; -; Genomic_DNA.
DR   EMBL; BC047773; AAH47773.1; -; mRNA.
DR   EMBL; BC069796; AAH69796.1; -; mRNA.
DR   EMBL; BC069803; AAH69803.1; -; mRNA.
DR   CCDS; CCDS3642.1; -. [O00238-1]
DR   CCDS; CCDS58919.1; -. [O00238-2]
DR   RefSeq; NP_001194.1; NM_001203.2. [O00238-1]
DR   RefSeq; NP_001243721.1; NM_001256792.1. [O00238-1]
DR   RefSeq; NP_001243722.1; NM_001256793.1. [O00238-2]
DR   RefSeq; NP_001243723.1; NM_001256794.1. [O00238-1]
DR   RefSeq; XP_011530503.1; XM_011532201.2. [O00238-1]
DR   RefSeq; XP_016864047.1; XM_017008558.1. [O00238-1]
DR   RefSeq; XP_016864048.1; XM_017008559.1. [O00238-1]
DR   RefSeq; XP_016864049.1; XM_017008560.1. [O00238-1]
DR   RefSeq; XP_016864050.1; XM_017008561.1. [O00238-1]
DR   UniGene; Hs.598475; -.
DR   PDB; 3MDY; X-ray; 2.05 A; A/C=168-502.
DR   PDBsum; 3MDY; -.
DR   ProteinModelPortal; O00238; -.
DR   SMR; O00238; -.
DR   BioGrid; 107126; 69.
DR   IntAct; O00238; 3.
DR   MINT; MINT-1340235; -.
DR   STRING; 9606.ENSP00000264568; -.
DR   BindingDB; O00238; -.
DR   ChEMBL; CHEMBL5476; -.
DR   GuidetoPHARMACOLOGY; 1789; -.
DR   iPTMnet; O00238; -.
DR   PhosphoSitePlus; O00238; -.
DR   BioMuta; BMPR1B; -.
DR   MaxQB; O00238; -.
DR   PaxDb; O00238; -.
DR   PeptideAtlas; O00238; -.
DR   PRIDE; O00238; -.
DR   DNASU; 658; -.
DR   Ensembl; ENST00000264568; ENSP00000264568; ENSG00000138696. [O00238-1]
DR   Ensembl; ENST00000394931; ENSP00000378389; ENSG00000138696. [O00238-1]
DR   Ensembl; ENST00000440890; ENSP00000401907; ENSG00000138696. [O00238-2]
DR   Ensembl; ENST00000509540; ENSP00000421671; ENSG00000138696. [O00238-1]
DR   Ensembl; ENST00000512312; ENSP00000425444; ENSG00000138696. [O00238-1]
DR   Ensembl; ENST00000515059; ENSP00000426617; ENSG00000138696. [O00238-1]
DR   GeneID; 658; -.
DR   KEGG; hsa:658; -.
DR   UCSC; uc003htm.5; human. [O00238-1]
DR   CTD; 658; -.
DR   DisGeNET; 658; -.
DR   GeneCards; BMPR1B; -.
DR   HGNC; HGNC:1077; BMPR1B.
DR   HPA; CAB009634; -.
DR   MalaCards; BMPR1B; -.
DR   MIM; 112600; phenotype.
DR   MIM; 603248; gene.
DR   MIM; 609441; phenotype.
DR   MIM; 616849; phenotype.
DR   neXtProt; NX_O00238; -.
DR   OpenTargets; ENSG00000138696; -.
DR   Orphanet; 2098; Acromesomelic dysplasia, Grebe type.
DR   Orphanet; 93396; Brachydactyly type A2.
DR   Orphanet; 93384; Brachydactyly type C.
DR   PharmGKB; PA25387; -.
DR   eggNOG; KOG2052; Eukaryota.
DR   eggNOG; ENOG410XQT0; LUCA.
DR   GeneTree; ENSGT00760000118876; -.
DR   HOGENOM; HOG000230587; -.
DR   HOVERGEN; HBG054502; -.
DR   InParanoid; O00238; -.
DR   KO; K13578; -.
DR   OMA; DGPIHHK; -.
DR   OrthoDB; EOG091G0BIU; -.
DR   PhylomeDB; O00238; -.
DR   TreeFam; TF314724; -.
DR   BRENDA; 2.7.10.2; 2681.
DR   Reactome; R-HSA-201451; Signaling by BMP.
DR   SignaLink; O00238; -.
DR   SIGNOR; O00238; -.
DR   ChiTaRS; BMPR1B; human.
DR   EvolutionaryTrace; O00238; -.
DR   GeneWiki; BMPR1B; -.
DR   GenomeRNAi; 658; -.
DR   PRO; PR:O00238; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000138696; -.
DR   CleanEx; HS_BMPR1B; -.
DR   ExpressionAtlas; O00238; baseline and differential.
DR   Genevisible; O00238; HS.
DR   GO; GO:0030425; C:dendrite; IEA:Ensembl.
DR   GO; GO:1990712; C:HFE-transferrin receptor complex; IC:BHF-UCL.
DR   GO; GO:0005887; C:integral component of plasma membrane; IC:UniProtKB.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0043235; C:receptor complex; TAS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IDA:HGNC.
DR   GO; GO:0001948; F:glycoprotein binding; IPI:BHF-UCL.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:HGNC.
DR   GO; GO:0004702; F:signal transducer, downstream of receptor, with serine/threonine kinase activity; IEA:InterPro.
DR   GO; GO:0046332; F:SMAD binding; IDA:HGNC.
DR   GO; GO:0005025; F:transforming growth factor beta receptor activity, type I; IEA:Ensembl.
DR   GO; GO:0004675; F:transmembrane receptor protein serine/threonine kinase activity; IMP:UniProtKB.
DR   GO; GO:0030509; P:BMP signaling pathway; IDA:BHF-UCL.
DR   GO; GO:0001502; P:cartilage condensation; NAS:UniProtKB.
DR   GO; GO:0071773; P:cellular response to BMP stimulus; IMP:BHF-UCL.
DR   GO; GO:0002063; P:chondrocyte development; ISS:AgBase.
DR   GO; GO:0009953; P:dorsal/ventral pattern formation; IEA:Ensembl.
DR   GO; GO:0060350; P:endochondral bone morphogenesis; ISS:AgBase.
DR   GO; GO:0001654; P:eye development; ISS:UniProtKB.
DR   GO; GO:0006954; P:inflammatory response; IEA:Ensembl.
DR   GO; GO:0035108; P:limb morphogenesis; IMP:UniProtKB.
DR   GO; GO:1902731; P:negative regulation of chondrocyte proliferation; ISS:AgBase.
DR   GO; GO:0001550; P:ovarian cumulus expansion; ISS:UniProtKB.
DR   GO; GO:0042698; P:ovulation cycle; ISS:UniProtKB.
DR   GO; GO:0030501; P:positive regulation of bone mineralization; IMP:BHF-UCL.
DR   GO; GO:0061036; P:positive regulation of cartilage development; ISS:AgBase.
DR   GO; GO:0045597; P:positive regulation of cell differentiation; IMP:UniProtKB.
DR   GO; GO:0032332; P:positive regulation of chondrocyte differentiation; ISS:UniProtKB.
DR   GO; GO:1902043; P:positive regulation of extrinsic apoptotic signaling pathway via death domain receptors; IEA:Ensembl.
DR   GO; GO:0045669; P:positive regulation of osteoblast differentiation; IMP:BHF-UCL.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:HGNC.
DR   GO; GO:0030166; P:proteoglycan biosynthetic process; ISS:AgBase.
DR   GO; GO:0060041; P:retina development in camera-type eye; IEA:Ensembl.
DR   GO; GO:0031290; P:retinal ganglion cell axon guidance; IEA:Ensembl.
DR   GO; GO:0001501; P:skeletal system development; IMP:UniProtKB.
DR   InterPro; IPR000472; Activin_recp.
DR   InterPro; IPR003605; GS_dom.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   InterPro; IPR000333; TGFB_receptor.
DR   PANTHER; PTHR23255; PTHR23255; 1.
DR   Pfam; PF01064; Activin_recp; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   Pfam; PF08515; TGF_beta_GS; 1.
DR   PRINTS; PR00653; ACTIVIN2R.
DR   SMART; SM00467; GS; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS51256; GS; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Cell membrane;
KW   Chondrogenesis; Complete proteome; Disease mutation; Disulfide bond;
KW   Dwarfism; Kinase; Magnesium; Manganese; Membrane; Metal-binding;
KW   Nucleotide-binding; Polymorphism; Receptor; Reference proteome;
KW   Serine/threonine-protein kinase; Signal; Transferase; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     13       {ECO:0000255}.
FT   CHAIN        14    502       Bone morphogenetic protein receptor type-
FT                                1B.
FT                                /FTId=PRO_0000024412.
FT   TOPO_DOM     14    126       Extracellular. {ECO:0000255}.
FT   TRANSMEM    127    148       Helical. {ECO:0000255}.
FT   TOPO_DOM    149    502       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      174    203       GS. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00585}.
FT   DOMAIN      204    494       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND     210    218       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   ACT_SITE    332    332       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING     231    231       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   DISULFID     32     53       {ECO:0000250|UniProtKB:P36898}.
FT   DISULFID     34     38       {ECO:0000250|UniProtKB:P36898}.
FT   DISULFID     47     71       {ECO:0000250|UniProtKB:P36898}.
FT   DISULFID     81     95       {ECO:0000250|UniProtKB:P36898}.
FT   DISULFID     96    102       {ECO:0000250|UniProtKB:P36898}.
FT   VAR_SEQ       1      1       M -> MGWLEELNWQLHIFLLILLSMHTRANFLDNM (in
FT                                isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045100.
FT   VARIANT      31     31       R -> C (in AMDD; unknown pathological
FT                                significance; mouse BMPR1B construct
FT                                containing this mutation shows reduced
FT                                GDF5-dependent receptor activation, mouse
FT                                BMPR1B construct containing this mutation
FT                                shows no loss of cell membrane
FT                                localization; dbSNP:rs745854387).
FT                                {ECO:0000269|PubMed:26105076}.
FT                                /FTId=VAR_075520.
FT   VARIANT      31     31       R -> H (in a gastric adenocarcinoma
FT                                sample; somatic mutation;
FT                                dbSNP:rs200035802).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041401.
FT   VARIANT      53     53       C -> R (in AMDD; mouse BMPR1B construct
FT                                containing this mutation shows loss of
FT                                GDF5-dependent receptor activation,
FT                                chicken BMPR1B construct containing this
FT                                mutation does not show reduced
FT                                chondrocyte differentiation, mouse BMPR1B
FT                                construct containing this mutation shows
FT                                no loss of cell membrane localization;
FT                                dbSNP:rs863225041).
FT                                {ECO:0000269|PubMed:24129431}.
FT                                /FTId=VAR_075521.
FT   VARIANT     149    149       R -> W (in dbSNP:rs34231464).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041402.
FT   VARIANT     200    200       I -> K (in BDA2; dbSNP:rs28939703).
FT                                {ECO:0000269|PubMed:14523231}.
FT                                /FTId=VAR_023819.
FT   VARIANT     224    224       R -> H (in dbSNP:rs35973133).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041403.
FT   VARIANT     297    297       D -> N (in a metastatic melanoma sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041404.
FT   VARIANT     325    325       K -> N (in BDA1D; acts in a dominant-
FT                                negative manner; dbSNP:rs869025614).
FT                                {ECO:0000269|PubMed:25758993}.
FT                                /FTId=VAR_076406.
FT   VARIANT     371    371       R -> Q (in dbSNP:rs34970181).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041405.
FT   VARIANT     486    486       R -> Q (in brachydactyly type C and BDA2;
FT                                with also additional features of
FT                                symphalangism-1; dbSNP:rs121434419).
FT                                {ECO:0000269|PubMed:16957682}.
FT                                /FTId=VAR_037967.
FT   VARIANT     486    486       R -> W (in BDA2; dbSNP:rs28939704).
FT                                {ECO:0000269|PubMed:14523231}.
FT                                /FTId=VAR_023820.
FT   HELIX       176    186       {ECO:0000244|PDB:3MDY}.
FT   STRAND      190    192       {ECO:0000244|PDB:3MDY}.
FT   HELIX       194    197       {ECO:0000244|PDB:3MDY}.
FT   HELIX       200    203       {ECO:0000244|PDB:3MDY}.
FT   STRAND      205    213       {ECO:0000244|PDB:3MDY}.
FT   STRAND      216    223       {ECO:0000244|PDB:3MDY}.
FT   STRAND      226    234       {ECO:0000244|PDB:3MDY}.
FT   HELIX       235    237       {ECO:0000244|PDB:3MDY}.
FT   HELIX       238    248       {ECO:0000244|PDB:3MDY}.
FT   STRAND      261    268       {ECO:0000244|PDB:3MDY}.
FT   HELIX       270    272       {ECO:0000244|PDB:3MDY}.
FT   STRAND      274    279       {ECO:0000244|PDB:3MDY}.
FT   HELIX       287    293       {ECO:0000244|PDB:3MDY}.
FT   HELIX       298    316       {ECO:0000244|PDB:3MDY}.
FT   STRAND      337    340       {ECO:0000244|PDB:3MDY}.
FT   STRAND      346    348       {ECO:0000244|PDB:3MDY}.
FT   HELIX       375    377       {ECO:0000244|PDB:3MDY}.
FT   HELIX       380    383       {ECO:0000244|PDB:3MDY}.
FT   HELIX       393    411       {ECO:0000244|PDB:3MDY}.
FT   TURN        426    430       {ECO:0000244|PDB:3MDY}.
FT   HELIX       437    444       {ECO:0000244|PDB:3MDY}.
FT   HELIX       455    459       {ECO:0000244|PDB:3MDY}.
FT   HELIX       461    473       {ECO:0000244|PDB:3MDY}.
FT   HELIX       478    480       {ECO:0000244|PDB:3MDY}.
FT   HELIX       484    496       {ECO:0000244|PDB:3MDY}.
FT   TURN        497    499       {ECO:0000244|PDB:3MDY}.
SQ   SEQUENCE   502 AA;  56930 MW;  B283D9BF45535C79 CRC64;
     MLLRSAGKLN VGTKKEDGES TAPTPRPKVL RCKCHHHCPE DSVNNICSTD GYCFTMIEED
     DSGLPVVTSG CLGLEGSDFQ CRDTPIPHQR RSIECCTERN ECNKDLHPTL PPLKNRDFVD
     GPIHHRALLI SVTVCSLLLV LIILFCYFRY KRQETRPRYS IGLEQDETYI PPGESLRDLI
     EQSQSSGSGS GLPLLVQRTI AKQIQMVKQI GKGRYGEVWM GKWRGEKVAV KVFFTTEEAS
     WFRETEIYQT VLMRHENILG FIAADIKGTG SWTQLYLITD YHENGSLYDY LKSTTLDAKS
     MLKLAYSSVS GLCHLHTEIF STQGKPAIAH RDLKSKNILV KKNGTCCIAD LGLAVKFISD
     TNEVDIPPNT RVGTKRYMPP EVLDESLNRN HFQSYIMADM YSFGLILWEV ARRCVSGGIV
     EEYQLPYHDL VPSDPSYEDM REIVCIKKLR PSFPNRWSSD ECLRQMGKLM TECWAHNPAS
     RLTALRVKKT LAKMSESQDI KL
//
